|1.||Molfino, N A: 1 article (12/2000)|
|2.||Brasseur, N: 1 article (12/2000)|
|3.||van Lier, J E: 1 article (12/2000)|
|4.||Forget, A: 1 article (12/2000)|
|5.||el Jastimi, R: 1 article (12/2000)|
|6.||Ménard, I: 1 article (12/2000)|
|7.||Hamel, R: 1 article (12/2000)|
|1.||Breast Neoplasms (Breast Cancer)
08/01/1999 - "TH9402 photodynamic-cell-therapy process conditions recognized as safe for normal human haematopoietic stem cells and progenitors demonstrated the efficacy of the purging procedure on various leukaemias (including chronic-myelogenous-leukaemia as well as non-Hodgkin-leukaemias and metastatic-breast-cancer cell lines."
12/01/2000 - "The aim of this study was to evaluate the potential of the photosensitizer 4,5-dibromorhodamine methyl ester (TH9402), a dibrominated rhodamine derivative, to eradicate multiple myeloma (MM) and BC cell lines, while sparing more than 50% of normal pluripotential blood stem cells from healthy volunteers. "
12/01/2000 - "The absence of significant toxicity towards normal hematopoietic stem cells, combined with the 5 logs eradication of cancer cell lines induced by this procedure suggests that TH9402 offers an excellent potential as an ex vivo photodynamic purging agent for autologous transplantation in MM and BC treatment."
|2.||4,5-dibromorhodamine methyl ester
|1.||Tissue Therapy (Cell Therapy)